Superworth

OptimizeRx EV/EBIT OPRX

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2013.

Today, Oct 23, 2026
15.3×
7-year median
31.1×
Against its 7-year history
35th
percentile: 0 is its lowest day, 100 its highest
7-year range
6.7× to 375×
Peer median
17.4×

OptimizeRx's EV/EBIT is 15.3× as of Oct 23, 2026.

That is below its 7-year median of 31.1×, lower than on 65% of days in the last 7 years.

Over that time it ranged from 6.7× in May 2026 to 375× in Jun 2019.

The median for 10 credit services stocks of a similar size is 17.4×.

EV/EBIT over time

The dashed line is the 7-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far15.3×6.7×17.8×
202516.9×16.9×161×
2024n/m a value too high to mean anything
2023n/m a value too high to mean anything
2022n/m a value too high to mean anything
2021n/m a value too high to mean anything
2020n/m a value too high to mean anything
2019213×213×375×
2018n/m a value too high to mean anything
2017n/m a value too high to mean anything
201641.9×41.9×58.7×
201560.6×60.6×399×
201486.6×62.4×91.9×
201370.1×37.0×70.1×

Against its peers

Companies in Financial - Credit Services nearest OptimizeRx's size, closest first, today.

Where OptimizeRx ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on OptimizeRx

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.